Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 91.12 | N/A |
| PEG Ratio (TTM) | 0.39 | N/A |
| P/S Ratio (TTM) | 5.04 | N/A |
| P/B Ratio (TTM) | 3.11 | N/A |
| P/FCF Ratio (TTM) | 15.81 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.24% | N/A |
| ROE (TTM) | 3.59% | N/A |
| Net Profit Margin (TTM) | 0.70% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -389.85% | 365.28% | N/A |
| Revenue | -0.84% | 20.14% | N/A |
| Net Income | -425.69% | 49.82% | N/A |
| Cash Flow | -2.08% | 18.25% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.20 | N/A |
| Quick Ratio (TTM) | 5.20 | N/A |
| D/E Ratio (TTM) | 5.04 | N/A |
| Interest Coverage (TTM) | 0.74 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 2.62 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |